PDGFRB and glioblastoma: The inhibitory effect of CompC on PDGFR and downstream signaling proteins has also been demonstrated in other PDGFR-expressing cells, including MRC-5, BEAS-2B, VSMC, and A172 human glioblastoma cells [14].